Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Last updated: 2022
Clear all
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 202210 results available
- November 20221 results available
- October 20227 results available
- September 202213 results available
- August 202220 results available
- July 202212 results available
- June 202213 results available
- May 202210 results available
- April 202210 results available
- March 202213 results available
- February 202212 results available
- January 20229 results available
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 130 items.
Gas cylinders containing commercial grade oxygen instead of medical grade oxygen were delivered to homecare customers.
RecallHealth product recall | 2022-12-22
The concentration of the medicinal ingredient, sodium fluoride, is out of specification in the affected lot.
RecallHealth product recall | 2022-12-15
Affected lot may result in a false negative for skin test (peanut allergy).
RecallHealth product recall | 2022-12-14
Product sterility may be compromised in the affected lot.
RecallHealth product recall | 2022-12-14
On December 9, 2022, Health Canada authorized a new formulation of the bivalent vaccine, COMIRNATY Original & Omicron BA.4/BA.5, as a booster dose for active immunization against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory…
AlertHealth professional risk communication | 2022-12-09
Affected lot contains active ingredient (Cholecalciferol) levels outside of the labelled claim.
RecallHealth product recall | 2022-12-08
The colour is out of specification in the affected lot(s).
RecallHealth product recall | 2022-12-06
Affected lots may contain the presence of foreign matter.
RecallHealth product recall | 2022-12-05
OCALIVA received a Notice of Compliance with Conditions in May 2017 for the treatment of PBC, pending the results of trials to verify its clinical benefit.
OCALIVA is now contraindicated for PBC patients with advanced disease, such as those with Child…
AlertHealth professional risk communication | 2022-12-05
Affected lot being voluntarily recalled due to a series of adverse reactions.
RecallHealth product recall | 2022-12-01
GlaxoSmithKline Consumer Healthcare ULC is recalling one lot of TUMS Peppermint Regular Strength tablets after some tablets were found to contain fragments of fibreglass and other material, including paper and aluminum foil. The product is sold in a…
AlertPublic advisory | 2022-11-30
The seals of the affected batch may be defective.
RecallHealth product recall | 2022-10-18
Since earlier this year, supplies of various formats of non-prescription pediatric/infant and children’s acetaminophen and ibuprofen products have been limited in retail and pharmacy locations and hospitals across Canada. This shortage is due to…
AlertPublic advisory | 2022-10-07
On October 7, 2022, Health Canada authorized the bivalent vaccine, COMIRNATY Original & Omicron BA.4/BA.5, as a booster dose for active immunization against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2…
AlertHealth professional risk communication | 2022-10-07
Syringes may be cracked in affected lot.
RecallHealth product recall | 2022-10-07